SmallCap Public Relations – The Gift That Keeps On Giving

In a new post on IRMagazine.com, Jeffrey Goldberger of KCSA Strategic Communications discussed “Public relations: The lifeline for clinical-stage micro-cap pharma companies.” According to Goldberger, the lack of news flow (especially microcap life science companies) results in lower stock price and trading volume which ultimately decreases a microcap companies ability to raise equity capital. There are three traditional IR chances for
Read more